Showing 1 - 10 of 11
Globlex eyes 2026 growth in wealth management
Business, Nuntawun Polkuamdee, Published on 09/12/2025
» Globlex Securities (GBS) is intensifying its focus on wealth management for 2026, placing portfolio diversification at the core of its investment strategy as the Thai stock market continues to grapple with structural and sentiment-driven challenges.
Brokerages advise clients to buy 'safe' stocks amid war
Business, Nuntawun Polkuamdee, Published on 18/10/2023
» Investors are being advised to buy and hold oil and high-dividend stocks as well as securities related to domestic consumption to avoid fluctuations from negative global factors such as the Israel-Hamas war, according to analysts.
Thai stocks set to remain volatile in Q2
Business, Nuntawun Polkuamdee, Published on 19/04/2023
» The Thai stock market is expected to remain volatile in the second quarter of this year, with analysts attributing the wild swings to concerns over rising interest rates, problems in the financial system and the risk of recession.
Thai stock investors urged to be careful
Business, Nuntawun Polkuamdee, Published on 01/02/2023
» As the Thai stock market has recovered rapidly over the past month in light of the improving economic picture, there are still some risk factors for shares in 2023 that investors should be aware of, analysts warn.
A child killer meets its match
Oped, Published on 22/11/2022
» Like many others, I spent much of the last few years in isolation to avoid getting sick. And now we are learning that this widespread disappearing act produced some unexpected side effects. In particular, infections from once-common illnesses -- like influenza and Respiratory Syncytial Virus (RSV) -- plummeted.
Globlex keen on firms using cannabis
Business, Poonyapat Luenam, Published on 09/06/2022
» Globlex Securities Company Ltd (GBS) recommends buying stocks that will benefit from the legalisation of cannabis, which is due to happen on Thursday.
Pfizer offers to sell medicines at cost to poorest countries
AFP, Published on 25/05/2022
» DAVOS (SWITZERLAND) - US pharmaceutical giant Pfizer on Wednesday said it would sell its patented drugs on a not-for-profit basis to the world's poorest countries, as part of a new initiative announced at the World Economic Forum in Davos.
GBX offers new services in digital transformation
Business, Nuntawun Polkuamdee, Published on 11/04/2022
» SET-listed Globlex Holding Management (GBX), a holding company and gold trader, plans to launch services related to digital assets and new products to support all kinds of investment in 2022.
Shares in several sectors set to gain as lockdown eased
Business, Nuntawun Polkuamdee, Published on 29/09/2021
» Stocks of cinemas, restaurants, retailers and department stores that were laggards during the lockdown can expect growth after the curfew is relaxed, said analysts from GBS Globlex Securities and Country Group Securities (CGS).
Nerve disorder listed as 'very rare' side effect of AstraZeneca vaccine
AFP, Published on 09/09/2021
» THE HAGUE: The European Medicines Agency has listed the neurological disorder Guillain-Barre syndrome, which can cause temporary paralysis, as a "very rare" side effect of the AstraZeneca Covid-19 vaccine.